Personalized Medicine and the Contradictions and Limits of First-Generation Deescalation Trials in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer

JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):99-100. doi: 10.1001/jamaoto.2017.2308.

Authors

Ester Orlandi¹, Lisa Licitra^{2

3}

Affiliations

¹ Radiotherapy 2 Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
³ University of Milan, Italy.

PMID: 29167895
DOI: 10.1001/jamaoto.2017.2308

No abstract available

MeSH terms

Humans
Oropharyngeal Neoplasms / therapy*
Oropharyngeal Neoplasms / virology*
Papillomavirus Infections / therapy*
Precision Medicine*